Great West Life Assurance Co. Can lifted its position in Medidata Solutions Inc (NASDAQ:MDSO) by 4.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,943 shares of the company’s stock after buying an additional 1,503 shares during the quarter. Great West Life Assurance Co. Can owned about 0.06% of Medidata Solutions worth $2,815,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the stock. Champlain Investment Partners LLC lifted its holdings in shares of Medidata Solutions by 15.7% during the first quarter. Champlain Investment Partners LLC now owns 2,148,615 shares of the company’s stock worth $134,955,000 after buying an additional 291,630 shares in the last quarter. Janus Henderson Group PLC raised its stake in Medidata Solutions by 69.7% in the second quarter. Janus Henderson Group PLC now owns 1,904,094 shares of the company’s stock valued at $153,394,000 after purchasing an additional 782,194 shares in the last quarter. American Century Companies Inc. raised its stake in Medidata Solutions by 3.5% in the second quarter. American Century Companies Inc. now owns 1,494,796 shares of the company’s stock valued at $120,421,000 after purchasing an additional 50,370 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in Medidata Solutions by 2.8% in the second quarter. Canada Pension Plan Investment Board now owns 1,111,500 shares of the company’s stock valued at $89,542,000 after purchasing an additional 29,800 shares in the last quarter. Finally, Fred Alger Management Inc. raised its stake in Medidata Solutions by 87.3% in the second quarter. Fred Alger Management Inc. now owns 1,068,170 shares of the company’s stock valued at $86,052,000 after purchasing an additional 497,817 shares in the last quarter.
A number of research firms recently commented on MDSO. Royal Bank of Canada dropped their price target on Medidata Solutions to $91.00 and set an “outperform” rating for the company in a research note on Tuesday, September 25th. Zacks Investment Research cut Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Thursday, June 21st. JPMorgan Chase & Co. cut Medidata Solutions from an “overweight” rating to a “neutral” rating and set a $87.00 target price on the stock. in a research report on Tuesday, July 24th. ValuEngine cut Medidata Solutions from a “buy” rating to a “hold” rating in a research report on Tuesday, July 24th. Finally, Needham & Company LLC lifted their target price on Medidata Solutions from $80.00 to $90.00 and gave the company a “buy” rating in a research report on Wednesday, June 13th. One analyst has rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the stock. Medidata Solutions has an average rating of “Buy” and an average price target of $87.17.
In other news, EVP Michael I. Otner sold 9,288 shares of the company’s stock in a transaction that occurred on Tuesday, July 24th. The stock was sold at an average price of $81.03, for a total transaction of $752,606.64. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Rouven Bergmann sold 3,000 shares of the stock in a transaction on Thursday, July 19th. The shares were sold at an average price of $85.36, for a total value of $256,080.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 29,788 shares of company stock worth $2,325,937. Insiders own 4.70% of the company’s stock.
MDSO stock traded down $1.17 during trading on Monday, hitting $69.85. The company had a trading volume of 564,000 shares, compared to its average volume of 623,687. Medidata Solutions Inc has a one year low of $59.60 and a one year high of $88.87. The stock has a market capitalization of $4.37 billion, a PE ratio of 82.41, a PEG ratio of 4.59 and a beta of 1.44. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.41 and a quick ratio of 1.41.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Tuesday, July 24th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.04. Medidata Solutions had a return on equity of 11.37% and a net margin of 9.13%. The firm had revenue of $155.90 million for the quarter, compared to analyst estimates of $155.86 million. During the same period in the previous year, the firm earned $0.31 earnings per share. The company’s revenue was up 14.6% compared to the same quarter last year. As a group, research analysts expect that Medidata Solutions Inc will post 0.79 earnings per share for the current year.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
See Also: Dividend Aristocrat Index
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.